Today, invasive procedures like laparoscopy etc. are
becoming better with medical robotics and computer assisted surgery (MRCAS).
Here, accessories to operate on patients are driven by computer assistance and
devices, which directly help the surgeons to complete the regimen in shorter
time, making smaller and perfect invasions on the body. As market research in MRCAS, the cost to it a bit expensive. For e.g.
each system has an estimate cost of $1 million to $2.5 million, and the
treatment can cost a person between $3,200 and $8,000.
A 2011 report on medical manufacturing suggested that these
machines were $2 billion worth with annual growth at 30.7 percent. The growth
and revenue projected to rise at CAGR 14.9% going to $4.2 billion for the next
five years. The robotic and computer assisted equipments offer increased
dimensional and placement accuracy with consistent outcome. It is used greatly
in detecting tumors in the organs to knee replacements, and treating uterine
fibroids etc.
Industry Analysis: Segments, Applications,
Key Players, and Audiences
Patients also reduce spending on hospital stay duration by
one and a half or two days. More than conventional surgical methods, MRCAS is
preferred due to advanced technology used. The global robotic surgery system industry is segmented by needle
drivers, forceps, 3D vision, motion control, retractors, cameras, and others.
It is also segregated by applications depending on surgeries relate to urology,
gastrointestinal, cardiothoracic, pediatric, gynecology, oncology, and others.
· Some of the vendors or key players in the
industry are Hitachi Medical Systems, Biobot surgical, Titan Medical Inc, Intuitive
surgical, Smith & Nephew and Siemens Healthcare, Robotic Systems and
Technologies, Ascension, MAKO Surgical, and Schaerer Mayfield.
· The geographic prominence is seen in
Asia-Pacific, North America, RoW, and Europe, with key audiences being clinics,
hospitals, and producers of surgical robotic tools. These devices provide
improved intervention, intra-operative information etc.
Where is MRCAS Used in Medical Treatments?
MRCAS is valuable for safe, easy, and cheap ultrasound
technology, prostate brachytherapy, kidney or liver tumor ablation, direct
observation of organs or tissues, external beam radiation therapy, and external
tracking with registration etc. The intended healthcare benefits are enhanced surgical precision, decline in
patient’s trauma, and shorter recovery time.
· The minimally invasive surgeries have equipped
computer system filters that reduce physician hand tremors, and inpatient
hospital day. It is best for pelvic, abdominal, neurological procedures.
· Steerable needles allow surgeons accessing
spaces, which are difficult to do manually. In cancer treatment accurate
imaging guidance is obtained for deformed tissues.
No comments:
Post a Comment